中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

9 records (took 0.013 seconds)

    Oral compositions
    2.
    发明授权
    Oral compositions 有权
    口服成分

    公开(公告)号：US09468225B2

    公开(公告)日：2016-10-18

    申请号：US14179170

    申请日：2014-02-12

    Applicant: Symrise AG

    Inventor： Jakob Ley ,  Sabine Widder ,  Veronika Somoza ,  Barbara Rohm ,  Matthias Zaunschirm ,  Gerhard Krammer

    IPC: A61K31/16 ,  A61K31/164 ,  A23K20/105 ,  A23K1/16 ,  A23L1/29 ,  A23L1/30

    CPC classification number: A23K20/105 ,  A23L33/10 ,  A23L33/30 ,  A61K31/16 ,  A61K31/164

    Abstract: Suggested are new compositions for oral ingestion, comprising at least one active agent from the group of alkamides. The compositions which are orally ingested reduce the uptake of free fatty acids in the adipocytes and at the same time stimulate the release of serotonin and dopamine, which leads to a reduction of appetite, a feeling of satiety and a positive mood. In doing so, the new compositions are thus perfectly suitable to counteract any undesired gain of weight.

    Abstract translation: 建议的是用于口服摄取的新组合物，其包含至少一种来自该组烷酰胺的活性剂。 口服摄入的组合物降低脂肪细胞中游离脂肪酸的摄取量，同时刺激5-羟色胺和多巴胺的释放，这导致食欲降低，饱腹感和积极情绪。 因此，新组合物非常适合抵消任何不希望的重量增益。

    Substance mixtures
    3.
    发明授权
    Substance mixtures 有权

    公开(公告)号：US10813378B2

    公开(公告)日：2020-10-27

    申请号：US15310191

    申请日：2015-06-03

    Applicant: SYMRISE AG

    Inventor： Sabine Widder ,  Kathrin Langer ,  Gerhard Krammer ,  Olga Pauli ,  Cornelia Homner

    IPC: A23L33/17 ,  A23L29/262 ,  A23L27/00 ,  A23L33/175 ,  A23L33/105

    Abstract: The invention relates to substance mixtures which contain (a) sodium carboxymethyl cellulose and (b) at least one bitter principle selected from the group consisting of xanthines, phenolic glycosides, flavanoid glycosides, hydrolysable or non-hydrolysable tannins, flavones and the glycosides thereof, caffeic acid and the esters thereof, terpenoid bitter principles, catechin, epicatechin, epigallocatechin, gallocatechin, gallocatechin-3-gallate, leucine, isoleucine, valine, tryptophan and phenylalanine, protein hydrolysates, peptides and metal salts and their mixtures, and optionally (c) dextrins, with the proviso that the components (a) and (b) are in the weight ratio of from 1:1 to 1:1,000.

    ORAL COMPOSITIONS
    7.
    发明申请
    ORAL COMPOSITIONS 有权
    口腔组成

    公开(公告)号：US20140234412A1

    公开(公告)日：2014-08-21

    申请号：US14179170

    申请日：2014-02-12

    Applicant: Symrise AG

    Inventor： Jakob Ley ,  Sabine Widder ,  Veronika Somoza ,  Barbara Rohm ,  Matthias Zaunschirm ,  Gerhard Krammer

    IPC: A61K31/16 ,  A23K1/16 ,  A23L1/30

    CPC classification number: A23K20/105 ,  A23L33/10 ,  A23L33/30 ,  A61K31/16 ,  A61K31/164

    Abstract: Suggested are new compositions for oral ingestion, comprising at least one active agent from the group of alkamides. The compositions which are orally ingested reduce the uptake of free fatty acids in the adipocytes and at the same time stimulate the release of serotonin and dopamine, which leads to a reduction of appetite, a feeling of satiety and a positive mood. In doing so, the new compositions are thus perfectly suitable to counteract any undesired gain of weight.

    Abstract translation: 建议的是用于口服摄取的新组合物，其包含至少一种来自该组烷酰胺的活性剂。 口服摄入的组合物降低脂肪细胞中游离脂肪酸的摄取量，同时刺激5-羟色胺和多巴胺的释放，这导致食欲降低，饱腹感和积极情绪。 因此，新组合物非常适合抵消任何不希望的重量增加。

Patent Agency Ranking